Related references
Note: Only part of the references are listed.Clinical Trials Supporting the Role of the IL-17/IL-23 Axis in Axial Spondyloarthritis
Angela Ceribelli et al.
FRONTIERS IN IMMUNOLOGY (2021)
Development of an IL-17A DNA Vaccine to Treat Systemic Lupus Erythematosus in Mice
Hiroshi Koriyama et al.
VACCINES (2020)
What Does Human Leukocyte Antigen B27 Have to Do with Spondyloarthritis?
Hanna Fahed et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2020)
Paradoxical gastrointestinal effects of interleukin-17 blockers
Marine Fauny et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Future Directions of Therapeutic Vaccines for Chronic Diseases
Ryo Nakamaru et al.
CIRCULATION JOURNAL (2020)
Multifactorial Design of a Supramolecular Peptide Anti-IL-17 Vaccine Toward the Treatment of Psoriasis
Lucas S. Shores et al.
FRONTIERS IN IMMUNOLOGY (2020)
HLA-B27 prevalence in axial spondyloarthritis patients and in blood donors in a Lebanese population: Results from a nationwide study
Nelly Ziade et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2019)
The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies
Dennis G. McGonagle et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Interleukin-17A Inhibition Diminishes Inflammation and New Bone Formation in Experimental Spondyloarthritis
Melissa N. van Tok et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Role of the IL-23/IL-17 Axis in Psoriasis and Psoriatic Arthritis: The Clinical Importance of Its Divergence in Skin and Joints
Marie-Astrid Boutet et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Development of vaccine for dyslipidemia targeted to a proprotein convertase subtilisin/kexin type 9 (PCSK9) epitope in mice
Ryo Kawakami et al.
PLOS ONE (2018)
The Initiation, but Not the Persistence, of Experimental Spondyloarthritis Is Dependent on Interleukin-23 Signaling
Melissa N. Van Tok et al.
FRONTIERS IN IMMUNOLOGY (2018)
Effects of the IL-23-IL-17 pathway on bone in spondyloarthritis
Ellen M. Gravallese et al.
NATURE REVIEWS RHEUMATOLOGY (2018)
Recent Advances in Therapeutic Vaccines to Treat Hypertension
Hironori Nakagami et al.
HYPERTENSION (2018)
Therapeutic Vaccine Against S100A9 (S100 Calcium-Binding Protein A9) Inhibits Thrombosis Without Increasing the Risk of Bleeding in Ischemic Stroke in Mice
Tomohiro Kawano et al.
HYPERTENSION (2018)
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological diseasemodifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial
Desiree van der Heijde et al.
LANCET (2018)
Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1
Philip J. Mease et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Pathogenesis of ankylosing spondylitis - recent advances and future directions
Vidya Ranganathan et al.
NATURE REVIEWS RHEUMATOLOGY (2017)
IL-17 Signaling: The Yin and the Yang
Nilesh Amatya et al.
TRENDS IN IMMUNOLOGY (2017)
A peptide vaccine targeting angiotensin II attenuates the cardiac dysfunction induced by myocardial infarction
Ryo Watanabe et al.
SCIENTIFIC REPORTS (2017)
Innate Immune Activation Can Trigger Experimental Spondyloarthritis in HLA-B27/Huβ2m Transgenic Rats
Melissa N. van Tok et al.
FRONTIERS IN IMMUNOLOGY (2017)
HLA B27 antigen in Middle Eastern and Arab countries: systematic review of the strength of association with axial spondyloarthritis and methodological gaps
Nelly Raymond Ziade
BMC MUSCULOSKELETAL DISORDERS (2017)
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn's Disease
Stephan R. Targan et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
Ankylosing Spondylitis and Axial Spondyloarthritis
Joel D. Taurog et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
Dominique Baeten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis
Philip J. Mease et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Therapeutic vaccine against DPP4 improves glucose metabolism in mice
Zhengda Pang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial
Dominique Baeten et al.
LANCET (2013)
Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci
Adrian Cortes et al.
NATURE GENETICS (2013)
Decrease in Blood Pressure and Regression of Cardiovascular Complications by Angiotensin II Vaccine in Mice
Futoshi Nakagami et al.
PLOS ONE (2013)
Autoimmune epididymoorchitis is essential to the pathogenesis of male-specific spondylarthritis in HLA-B27-transgenic rats
Joel D. Taurog et al.
ARTHRITIS AND RHEUMATISM (2012)
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
Wolfgang Hueber et al.
GUT (2012)
An IL-17 peptide-based and virus-like particle vaccine enhances the bioactivity of IL-17 in vitro and in vivo
Q. Guan et al.
IMMUNOTHERAPY (2012)
Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis?
Uta Kiltz et al.
ARTHRITIS CARE & RESEARCH (2012)
The Early Disease Stage in Axial Spondylarthritis Results From the German Spondyloarthritis Inception Cohort
Martin Rudwaleit et al.
ARTHRITIS AND RHEUMATISM (2009)
Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis
Catherine Uyttenhove et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice
A Ogawa et al.
CLINICAL IMMUNOLOGY (2004)
Prevention of the onset and progression of collagen-induced arthritis in rats by the potent p38 mitogen-activated protein kinase inhibitor FR167653
M Nishikawa et al.
ARTHRITIS AND RHEUMATISM (2003)
Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis
E Feldtkeller et al.
RHEUMATOLOGY INTERNATIONAL (2003)
Share Paper
